期刊文献+

剪切因子Im25在血管平滑肌细胞中的缺失对小鼠高脂血症的影响

Effects of cleavage factor Im25 downregulation in vascular smooth muscle cells on hyperlipidemia in mice
原文传递
导出
摘要 目的探讨剪切因子Im25(CFIm25)在平滑肌细胞(VSMCs)中的缺失对高脂血症的影响.方法构建VSMCs中特异性敲除CFIm25的小鼠(CFIm25^(f/+)TaglnCre)和对照小鼠(TaglnCre)模型;通过对两种不同基因型的小鼠喂养正常饮食或高脂肪饮食(HFD)18周,监测小鼠的体重变化;采用ELISA法检测血清总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)及低密度脂蛋白胆固醇(LDL-C)水平;采用油红O染色评估小鼠主动脉脂质沉积程度.结果HFD喂养期间,CFIm25^(f/+)TaglnCre小鼠体重明显高于对照组[雄性:(1.01±0.06)g和(0.87±0.31)g,t=7.53,P<0.05;雌性:(0.64±0.02)g和(0.35±0.04)g,t=9.68,P<0.05];HFD喂养18周后,CFIm25^(f/+)TagInCre小鼠的TC[(6.80±0.35)mmol/L和(3.76±0.87)mmol/L,t=5.63,P=0.004]、TG[(0.97±0.21)mmol/L和(0.42±0.10)mmol/L,t=4.08,P=0.015]和LDL-C[(5.20±0.30)mmol/L和(2.00±0.98)mmol/L,t=5.40,P=0.006]水平均高于TaglnCre组,其中TC增加80.72%,TG增加132.79%,LDL-C增加160.32%;CFIm25f/+TaglnCre小鼠主动脉中脂质沉积明显增多,粥样硬化斑块面积增加(均P<0.05).结论小鼠VSMCs中CFIm25的缺失加重了高脂血症,并加速了动脉粥样硬化病变形成. Objective To investigate the impact of cleavage factor Im25(CFIm25)on VSMCs-specific knockdown in the context of hyperlipidemia.Methods Mice models were constructed with specific knockout of CFIm25 in VSMCs(CFIm25f/+TaglnCre)and control mice(TaglnCre).The mice were fed a normal diet or high-fat diet(HFD)for 18 weeks and their body weight changes were monitored.ELISA was used to measure serum total cholesterol(TC),triacylglycerol(TG),high-density lipoprotein(HDL-C)and low-density lipoprotein(LDL-C)levels.The extent of aortic lipid deposition in mice was assessed by oil red O staining.Results During the feeding of a high-fat diet,CFIm25f/+TaglnCre mice showed a significant increase in body weight compared to the control group[Male(1.01±0.06)g and(0.87±0.31)g,t=7.53,P<0.05;Female:(0.64±0.02)g and(0.35±0.04)g,t=9.68,P<0.05].After 18 weeks of high-fat diet feeding,CFIm25f/+TaglnCre mice had significantly higher levels of TC[(6.80±0.35)mmol/L and(3.76±0.87)mmol/L,t=5.63,P=0.004],TG[(0.97±0.21)mmol/L and(0.42±0.10)mmol/L,t=4.08,P=0.015],and LDL-C[(5.20±0.30)mmol/L and(2.00±0.98)mmol/L,t=5.40,P=0.006]compared to the TaglnCre group.Specifically,TC levels increased by 80.72%,TG increased by 132.79%,and LDL-C increased by 160.32%.There was a significant increase in aorta lipid deposition and atherosclerotic plaque area in CFIm25f/+TaglnCre mice(P<0.05).Conclusions The research indicated that VSMCs-specific CFIm25 knockdown in mice further worsened hyperlipidemia and atherosclerotic lesions.
作者 李清宝 王宇 叶科峰 李欣欣 姚子童 姜磊 黄菁菁 Li Qingbao;Wang Yu;Ye Kefeng;Li Xinxin;Yao Zitong;Jiang Lei;Huang Jingjing(Cardiac Surgery Department,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250021,China;Geriatrics Department,the Fourth Affiliated Hospital of Nanjing Medical University,Nanjing 210031,China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2023年第9期1105-1109,共5页 Chinese Journal of Geriatrics
基金 江苏省老年健康科研项目(LK2021030) 江苏省老年医学临床技术应用研究项目单位项目(LD2022003) 江苏省老年医学临床技术应用研究项目带头人项目(LD2022011)。
关键词 高脂血症 剪切激活因子 平滑 血管 Hyperlipidemia Cleavage stimulation factor Muscle,smooth,vascular
  • 相关文献

参考文献6

二级参考文献75

  • 1血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量:222
  • 2Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force an Practice Guidelines [J]. J An: Coil Cardiol, 2014, 63 ( 25PtB ) : 2889-934. DOI: 10. 1016/j. jacc. 2013.11. 002.
  • 3MiettinenTA, PyOrS.1/ K, ()lsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin survival study (4s)[J]. Circulation, 1997, 96(12): 4211-4218.
  • 4Packard CJ, Ford I, Murray H, et al. Lifetime clinical and economic benefits of statin-based 1.1-)L lowering in the 20-year followup of the west of Scotland coronary prevention study [G]. American Heart Association, 2014.
  • 5Scientific Sessions. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial [J]. Lancet, 2002, 360(9346): 1623-1630.
  • 6Lloyd SM, Stott DJ, de Craen A J, et al. Long term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) [J]. PLoS One, 2013, 8 ( 9 ): e72642. DOI: 10.1371/ journal, pone. 0072642.
  • 7Athyros VG, IKatsiki N, Tziornalos K, et al. Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study[J]. Arch Med Sci, 2013, 9 ( 3 ).- 418426. DOI: 10. 5114/ aoms. 2013. 35424.
  • 8GrundySM, Arai H, Barter P, et al. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary [ J ] Atherosclerosis, 2014, 232 (2): 410-413. DOI.. 10. 1016/j. atherosclerosis. 2013.11. 031.
  • 9Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient- centered management of dyslipidemia., part 1- executive summary[J]. J Clin Lipidol, 2014, 8 (5) .. 473-488. DOI.. 10. 1016/j. jacl. 2014.07. 007.
  • 10Razzolini R, Tarantini G, Ossena G, et at. Non- cardiovascular mortality, low-density lipoprotein cholesterol and statins: a meta-regression analysis [J]. Cardiology, 2007, 109 (2) ; 110-116.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部